To test if Raman spectroscopy (RS) is an appropriate tool for the diagnosis and possibly grading of prostate cancer (PCa).
Introduction
Prostate cancer (PCa) is often impossible to detect with conventional imaging techniques [1, 2] , except in the case of high grade cancer patterns (e.g. cribriform patterns), where contrast can be observed using MRI. The standard of care for PCa diagnosis relies on a TRUS-guided needle biopsy technique [3, 4] . Because of the inability of clinical imaging to detect PCa either preoperatively or intra-operatively, current needle biopsy procedures lead to low diagnostic yields. TRUSguided biopsies are associated with false-negative rates between 15% and 34%, leading to repeat biopsies, up to 28% of which are found to be positive [4] , with significant upgrading and downgrading (~35% and 7-30%, respectively) when the whole prostate is examined after radical prostatectomy (RP) [5] [6] [7] [8] [9] . Although current guidelines take into account those limitations, unnecessary side effects or earlier recurrence still occur, and improving the diagnostic yield of prostate biopsies is central to patient management [5, 10] .
One way this could be achieved is through the development of highly sensitive and specific in situ optical spectroscopy tissue characterization techniques that would enhance the molecular information provided to clinicians during needle insertion. The resulting needle-guidance capabilities would allow more accurate tumour targeting, incidentally limiting the number of non-diagnostic biopsy samples before histopathological analysis by pathologists. Integration of optical techniques with current prostate biopsy procedures requires tissue information to be provided in real time using miniature fibre-optical systems to ensure minimal disruption of the surgeon workflow. Specifically, the new optical information would be used as a surrogate for the presence of cancer, with focal information allowing guidance to specific prostate zones in which histological confirmation is required for diagnostic and/or prognostication.
Raman spectroscopy (RS) is an optical technique that has been used to characterize multiple disease types, including in in vivo applications, and that has been shown to have the ability to disciminate between benign and cancer tissue in different organs, such as breast, skin and brain [11] . In PCa, the only existing RS studies were performed on cell lines [12, 13] or snap-frozen tissue sections [14, 15] . An important limitation of those studies is that tissue classification validation was achieved based on the overall patient diagnosis and not on local histology analysis co-registered with the optical measurements. In addition, the development of robust statistical models requires large numbers of measurements to ensure the full heterogeneity of benign and malignant tissue is captured [16] . The aim of the present study was to address those very important limitations by studying 32 prostates (947 co-registered spectra) to allow the development and clinical translation of new biopsy guidance techniques relying on the training and validation of supervised multivariate statistical models where histopathology information has to be provided for each RS measurement.
We present a detailed proof-of-principle study demonstrating that PCa tissue can be characterized with a single-point intraoperative RS fibre optic probe using a near-infrared laser to excite the vibrational modes of molecular bonds over a 500 lm field of view in <1 s. The RS information provides a global tissue fingerprint in terms of biomolecules, such as proteins, lipids and carbohydrates, as well as DNA and RNA [17] . This information is used to distinguish prostatic and extraprostatic tissue as well as to detect prostate tissue containing cancer of different grades. A highly precise spatial registration technique is presented, leading to the development of accurate statistical models that can later be used along with in vivo instruments to target biopsy needle placement and possibly guide surgical resection during RP procedures.
Materials and Methods

Patient Selection
Informed consent was obtained from the 32 patients involved in the study. Men with >2 cores harbouring PCa at biopsy with involvement of >10% of each positive core, who underwent first-line RP at the Centre hospitalier de l'Universit e de Montr eal (CHUM) and who had agreed to participate in the institutional PCa repository (CHUM Ethics Committees approval number 15.102) were recruited. Prostate specimens <35 g were excluded from the study. Clinical and pathological characteristics including age, preoperative PSA level, Grade Group (GG) from the core needle biopsy procedure, GG from whole-prostate pathology analysis after RP, pathological stage and the percentage of patients with positive surgical margins are shown in Table 1 . Biopsy pathology was assessed by pathologists both internal and external to the CHUM. The pathological staging of the primary tumour (pT) was determined from the prostate specimen by the pathologist according to the TNM staging system, seventh edition [18] . 
Specimen Handling
In the pathology ward, the prostates were weighed and inked according to institutional standards [19] . The fresh specimens were then wiped with a tissue soaked in a solution of formalin mixed with acetic acid for ink fixation in order to limit ink diffusion into sub-surface tissue. A prostate slice of 3-5 mm thickness was then cut in the transverse plane perpendicular to the urethra (Stage 1; Fig. 1B ) in the most probable cancer area according to the biopsy pathology report. The slice was then squeezed between two pieces of waxed cardboard and transferred in 0.9% NaCl (4°C) to the optical spectroscopy laboratory where RS measurements were made within 2 h of the RP surgical procedure. The specimen then reintegrated the standard pathology workflow for routine analysis based on microscopic haematoxylin, phloxine and saffron (HPS) staining.
Raman Spectroscopy System, Calibration Procedures and Data Acquisition
A handheld contact RS probe system was used for optical data acquisition after the interrogation of a 0.5 mm-diameter tissue area (Fig. 1A) , as described elsewhere [20, 21] . The probe has an outer diameter of 2.1 mm and is connected to an illumination/detection subassembly through a cable 3 m in length, composed of low hydroxyl content multimode fibres: seven fibres with a 300-lm core are used for detection and a central 272-lm core fibre is used for excitation. The inelastic back-scattered light resulting from tissue excitation is detected through a ring-shaped notch filter to remove elastic scattering and, in order to minimize the RS signal from the silica in the fibres, an in-line shortpass emission filter is used in front of the excitation fibre. For each tissue acquisition, the probe was placed in contact with the sample, and spectra were acquired associated with the background (laser turned off), followed by a series of 10 Raman spectra with an illumination/detection exposure time of 50 ms. Saturation was avoided by tuning the laser power between 5 and 150 mW depending on the intensity of the tissue autofluorescence background. All measurements were taken at room temperature in the dark, to minimize contributions of ambient light in the detected signals. The following preprocessing steps were applied to the raw tissue data using a custom Matlab program (MathWorks, Natick, MA, USA): (i) an average spectrum was calculated from the 10 tissue measurements; (ii) the background signal was subtracted from the average spectrum; (iii) the spectrum was corrected with the spectral response of NIST standard; (iv) a polynomial fit was used to remove residual low-frequency components including intrinsic tissue auto-fluorescence using a sixth degree polynomial fit; (v) the spectrum was normalized using standard normal variate normalization; and (vi) the Tylenol measurement was used for wavenumber x-axis calibration.
Spatial Registration of RS Measurements
For each prostate, 30-50 spectra were acquired on the basal or the apical section of the prostate (Stage 1; Fig. 1B ) with each measurement location marked with a drop of India ink (Stage 2; Fig. 1B ). After data acquisition, a photograph was taken and used to produce an image showing a twodimensional mask of the prostate slice contour and 1.5-mm diameter circles associated with each ink spot (Stage 3; Fig. 1B ). The diameter of the circles in the two-dimensional mask was chosen to be three times that of the RSinterrogated area (0.5-mm diameter) to offset potential imprecisions attributable to, for example, the diffusion of ink within the tissue, anisotropic deformations associated with subsequent processing steps (during fixation, hydration/ dehydration, paraffin embedding or tissue cutting) and imprecision during the prostate reconstruction process (see below). To ensure the ink-marked surface remained flat during preparation process leading to histological staining, the specimen was gently squeezed between two pieces of waxed cardboard, followed by immersion in formalin (10%) for fixation.
Whole HPS Prostate Slice Reconstruction
The tissue section slices were imaged with the Aperio Digital Pathology Slide Scanner (Leica Biosystems, Nussloch, Germany), followed by a manual image processing procedure leading to the production of a reconstructed HPS image consistent with the macroscopic photograph of the fresh prostate slice. The spatial registration accuracy between the stitched HPS image and the macroscopic image was potentially limited because of several factors including anisotropic tissue warping associated with tissue processing and uneven tissue level between adjacent slides. Under the supervision of a pathologist (D.T.) and a resident in pathology (V.Q.T.), digital fine-tuning was performed to remedy these possible sources of uncertainty by using anatomical landmarks (such as boundaries of cancerous nodules, ejaculatory ducts, prostatic urethra and benign prostate hypertrophic nodules) to ensure correct relative positioning of the slides with the fresh prostate slice photograph (Stage 4; Fig. 1B ).
Each prostate slice was characterized by a coefficient of reconstruction complexity (high, medium, low), according to the levels of image adjustments (along the x-and/or y-axis) that were necessary to obtain a satisfying reconstruction, the quality of correlation with macroscopic structures and the proportion of analysable tissue.
Correlation of Spectroscopy Measurements and Histology for Tissue Characterization and Categorization
The overlay of the whole HPS prostate slice and the twodimensional mask (Stage 4; Fig. 1B ) allowed histopathological analysis of each correlation tissue area (Fig. 1C) . Cancer is generally intermingled with benign glands and stroma. The malignant prostatic tissue class includes a variety of cancer surface distributions. In contrast, the spectra classified in the benign prostatic tissue contain only benign tissue, including benign glands and stroma. The circles had to be completely inside a cancer nodule or completely in benign tissue to be included in the dataset. Points were excluded when reconstruction was unsatisfying (absence of underlying tissue, point bordering the edge of a slide, uncertain localization), when histology was uncertain, when a benign site was in close proximity to a cancer zone or when the corresponding spectrum was contaminated by India ink. Additionally, the whole slide was excluded if the pathologist identified a 
Statistical Analysis
Univariate statistical analyses were performed using Matlab on several peaks for each classification scenario. For each analysed peak, a Kolmogorov-Smirnov test was applied to test if the data came from a normal distribution. In the case of normality, a two-sample F-test was performed to test for equality of variance. Then, a two-sample t-test was performed on the selected peaks. In the case of non-normality, a Wilcoxon rank sum test was performed. The corresponding P values are given in Table 1 and Fig. S1C .
Supervised machine-learning methods were used to classify the spectra of two classes using Neural Network with leaveone-out cross-validation [22] . The entire spectra were used (no feature selection) and the number of neurons was optimized for each classification test between two and 32 neurons to maximize classification accuracy. For each classification test the corresponding receiver-operating characteristic (ROC) curve was displayed. The sensitivity and specificity were deduced from the ROC curve by taking the nearest point of the ROC curve from the (0,1) point (the topleft corner of the plot). The accuracy was then deduced from the corresponding values.
To test the impact on the classification results of class sizes imbalance between benign (n = 776) and malignant (n = 149) prostatic tissues, we randomly chose five sub-sets (4*149 + 1*180) within the benign group. The complete test was reproduced 10 times (Fig. S3) . The results were reproducible on the 10 independent tests. Moreover, these results were not significantly different from the test using the whole set of benign spectra. We consequently neglected the group size imbalance for all our statistical analysis.
Sample sizes were chosen with the goal of achieving twosided 95% normal-based CIs of <AE5% for all reported classification results, based on cross-validation approaches. Sample sizes were smaller for some subgroups of tissue (for example, n < 30 spectra for some grades of cancer tissue), which results in greater uncertainty in the reported results for classifications between subgroups. In these cases, there is a more limited ability to accurately measure classification performance; however, the spectra exhibit biochemical changes between tissues which are consistent with known molecular species, bolstering the argument for distinguishing between these tissues based on Raman spectra.
Results
Patient Population, Specimen Handling and Spatial Correlation Between Spectroscopy Measurements and Histopathology
The patient cohort included 32 patients (Table 1) , who mostly had intermediate-and high-risk disease, with no patients with GG1 disease at RP. Extraprostatic extension and positive surgical margins were present for 19 and 10 patients, respectively, and 12 patients had a biopsy grade different from the one established after the RP procedure.
A handheld contact RS probe [20, 21] was used on 32 fresh prostate slices, namely one per patient (Fig. 1A) . For each specimen, spectroscopy data were acquired for up to 50 locations spatially registered with HPS histopathology tissue maps. Tissue areas considered for the local histopathology analyses were of 1.5 mm diameter, intentionally chosen to be larger than the 0.5-mm diameter area interrogated with the probe, to give a AE0.5-mm tolerance, limiting misclassification errors associated with potential spatial registration offsets (Fig. 1B) . From the reconstruction of the whole HPS prostate A total of 1 293 Raman spectra were acquired, for which detailed local pathology analysis was performed classifying interrogated points into categories to be used as the 'gold standard' against which molecular characterization based on RS was tested ( Figs 1C and 2 ). Spectra were excluded in case of Indian ink contamination (111), unsatisfying reconstruction (148), uncertain histology (22) or if a benign classified site was in close proximity to a cancer zone (65). Accordingly, a total of 947 spectra were included in the study. Histology analysis led to the determination of whether the interrogated tissue was prostatic or extraprostatic. It was also determined whether samples contained cancer and, if so, to what cancer grade the sample belonged according to the GG classification scheme. For benign tissue, the percentage of glands (0-24%, 25-49%, 50-74%, 75-100%) with respect to stromal tissue was determined at each point to be used as a surrogate for tissue heterogeneity. The distributions of the different groups and sub-groups of spectra are shown in Fig. 2 .
Vibrational Spectroscopy Signature of Prostatic Tissue
When comparing the Raman spectra from samples associated with prostatic tissue with extraprostatic samples (Fig. 3A ), significant differences (P < 0.001) were observed for peaks from molecular bonds associated with the presence of lipids (e.g. triglycerides; Table 2 ). Prostatic tissue samples showed higher amplitudes for peaks directly associated with the presence of proteins and nucleic acids, consistent with the higher cellularity of glands compared with adipose tissues (Fig. 3A and Table 2 ). Tissue classification based on statistical modelling was used to distinguish extra-from intraprostatic tissue with an accuracy of 83%, a sensitivity of 82%, a specificity of 83% and an ROC curve with and area under the curve (AUC) of 0.9 (Fig. 3B ). For analysis of the benign prostatic tissue only, peaks corresponding to collagen molecules, the main constituent of stroma, were set in a hierarchy according to the gland/stroma ratio (Fig. S1) ; the intensity of these peaks were maximal for stroma-rich tissue (0-24% of glands) and minimal for gland-rich tissue (75-100% of glands). Univariate analysis performed on these peaks demonstrated significant difference (P < 0.001) between the extremal groups (0-24% and 75-100% of glands; Fig. S1C ). These findings show that our dataset captures the heterogeneity of the prostatic tissue and that the approach can differentiate diverse morphological patterns intrinsic to the prostate.
Molecular Characteristics of Malignant Prostatic Tissue
Average spectra for benign tissue (n = 776) and tissue containing cancer cells (n = 149) were compared with peaks showing significant differences (P < 0.01; Fig. 4A ) and their molecular assignments ( Table 2 ). Peaks that were predominant in malignant tissue mainly involved the presence of DNA/RNA, which is consistent with an increased proliferation rate associated with cancer cells [23] . Benign and malignant tissue could be classified with an accuracy of 86%, a sensitivity of 87%, a specificity of 86%, and an AUC = 0.93 (Fig. 4B ). For 143/149 spectra from malignant areas, the grading in terms of cancer pattern according to the GG was established (six spectra were excluded because of grade uncertainty). The Raman spectroscopic characteristics of the different GGs were explored. The average spectra (Figs 5A and S5A) and corresponding ROC curves (Fig. 5B) (Table S1) , clinically relevant classifications were detailed. Machine learning classified correctly benign vs GG1 for 726/801 (91%), GG2 for 588/805 (73%), GG3 for 670/797 (84%), GG4 for 711/802 (88%) and GG5 for 729/818 spectra (89%). GG1 was accurately differentiated from GG2 for 34/54 (63%), from GG3 for 34/46 (74%), from GG4 for 42/51 (82%), and from GG5 for 56/67 spectra (84%). Univariate statistical analyses on specific peaks were performed for GG1 vs GG5 ( Table 2 ). The dominant peaks for the lower cancer grade (GG1) mostly involved proteins and lipids such as amide I, whereas the dominant peaks for the higher cancer grade (GG5) were related to the presence of DNA/RNA, consistent with a higher nucleic acid content in line with higher tumour grade [14, 23] .
Analyses were performed to assess the generality and robustness of our results. First, benign vs malignant classification performance was shown to improve as reconstruction complexity decreased, from AUC = 0.81-0.82, when only patients with high-medium reconstructions are considered, to AUC = 0.9 for low complexity reconstructions (Fig. S4) . This demonstrates the importance of ensuring optical data are spatially registered with high precision with the gold standard of histopathology. Then, to offset any classification biases linked with misbalance between the sizes of the benign (n = 776) and malignant (n = 149) categories, five data subsets were formed randomly within the benign Figs 3-5A . GG, Grade Group. ***P < 0.001, **P < 0.01, *P < 0.05 and NS, non-significant (P > 0.05).
References for band centre, molecular bond assignment and potential molecules for specific peaks are provided in the reference list [17, [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . group and statistical classification models made for each demonstrating comparable classification performances in each case with the malignant category (Fig. S3) . Finally, to confirm that the differences observed between benign and malignant prostatic tissue were attributable to the presence of cancer cells and not to an imbalance of gland/stroma ratio, we compared the spectra of benign and malignant tissue with similar gland/stroma ratio; namely, GG1 and benign tissue with 75-100% glands (Fig. S2) , which led to an ROC curve with AUC = 0.85, consistent with results reported including all gland/stroma ratios (Fig. 4) .
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Discussion
We developed a robust RS PCa detection technique based on high-precision spatial registration of single-point optical measurements with local histopathology analysis of ex vivo fresh prostate specimens. A total of 947 Raman spectra were acquired on post-prostatectomy samples from 32 patients. We used a tissue interrogation method ensuring the full heterogeneity (architectural, phenotypic and genotypic [24] [25] [26] ) of the prostate was captured despite the clinical reality that PCa, especially for lower grades, is often undetectable either visually or by palpation. To maximize the probability of detecting cancerous areas, optical spectroscopy data were acquired by sampling tissue according to pathology biopsy report and with up to 50 measurements per prostate slice, leading to 16% of all samples containing cancer. This cancer sampling rate is high, considering other groups were unable to localize malignant tissue in a study with similar goals to ours [27] .
Detailed histopathology analyses allowed each Raman spectrum to be associated with different categories of tissue prior to being submitted to a supervised machine-learning algorithm, leading to statistical models allowing binary tissue classification. The most salient results of our study include the finding that RS could distinguish extraprostatic from prostatic tissue (AUC = 0.9) and that, despite inclusion of all cancer grades (GG1-5), the technique was able to distinguish benign from malignant prostatic tissue (AUC = 0.93). The technique was also able to identify different PCa grades (GG1-5 compared with benign tissue), with AUCs between 0.84 and 0.95. Because spectromolecular differences are more pronounced between groups with larger GG number separations and benign tissue, we found that accuracy, sensitivity and specificity of detection increased accordingly.
The robustness of our results was verified, ensuring differences in gland/stroma ratios were not the underlying source of contrast driving classification and that no bias was introduced by an imbalance between the benign and malignant classes. We have also determined quantitatively that our confidence in the spatial registration between HPS pathology images and the location of probe measurement is an important factor determining the predictive accuracy of the models. This is a crucial point affecting the clinical translation of bio-optical technologies, concretely demonstrating that the accuracy of supervised optical techniques heavily relies on the ability to precisely associate measurements with the gold standard of histopathology or other ex vivo techniques such as immunohistochemistry. Our results also show that the ability of new optical tissue characterization methods to enhance the informational content provided during interventional procedures is intrinsically limited by the information that standard histology can provide.
Ultimately, the ability of the technique to detect and grade cancer as well as to distinguish prostatic from extraprostatic tissue can have a profound impact on interventional techniques in prostate oncology. For transperineal biopsies, the optical fibres of the probe could be integrated onto a currently used needle and the detected Raman signal used for guidance, ensuring that collected samples are representative of the disease before histopathological analysis. This could limit the number of biopsy procedures, thereby increasing overall procedural effectiveness and improving safety by diminishing septic shock risks. Ensuring representative samples are harvested could have a positive impact on patient outcomes by improving the diagnostic yield figures associated with current biopsy approaches that often lead to treatment planning that is not personalized to the actual pathology. The technique we have developed could also be used for other applications where histology is not routinely used, including guidance during RP and focal therapy, both situations in which there is an unmet clinical need to ensure optimum cancer control. A multi-step approach could be used, where the localization of the interrogated tissue would be confirmed (prostatic vs extraprostatic tissue), then, if prostatic, its malignancy would be determined and, if malignant, a grade could be attributed.
This translational proof-of-principle study presents a method of PCa identification using RS, that would have the potential to significantly improve the way PCa is diagnosed and treated, once validated in a prospective trial. 
Supporting Information
Additional Supporting Information may be found in the online version of this article: Figure S1 . Raman spectra of benign tissue with different gland/stroma ratio. Figure S2 . Benign (gland-rich) vs low-grade malignant tissue with similar gland/stroma ratio (75-100% of glands). Figure S3 . Randomized classification. Figure S4 . Classification results for benign and malignant tissues depending on the complexity of the reconstruction of the prostate slice from HPS images. Figure S5 . Classification results distinguishing benign from malignant tissue divided into the five grade groups (GGs). Table S1 . Recapitulative of the classification tests results including the number of spectra correctly or non-correctly classified using machine learning.
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